Key result
Novel homozygous DSP mutation linked to early-onset biventricular arrhythmogenic cardiomyopathy.
Case Report (n=1)
No
This case underscores the importance of integrating advanced imaging with genetic testing in early-onset cardiomyopathies and expands the phenotype of DSP-related disease.
BACKGROUND: A 23-year-old male with arrhythmic syncope and a presumed diagnosis of COVID-19 myocarditis was ultimately diagnosed with biventricular arrhythmogenic cardiomyopathy based on cardiac magnetic resonance imaging (MRI) and genetic testing (next-generation sequencing). CASE SUMMARY: The patient presented with recurrent syncope, frequent ventricular ectopics, and reduced left ventricular ejection fraction. Cardiac MRI revealed biventricular dysfunction and nonischemic late gadolinium enhancement with ring-like pattern. Genetic analysis identified a novel homozygous desmoplakin (DSP) mutation. He was treated with heart failure therapy and received an implantable cardioverter-defibrillator due to high arrhythmic risk. Family screening revealed heterozygous carriers among his relatives. DISCUSSION: This case underscores the importance of integrating advanced imaging with genetic testing in early-onset cardiomyopathies and expands the phenotype of DSP-related disease.
No takes yet. Share an insight, caveat, or question.
Giannoni et al. (2025) conducted a case report in Biventricular arrhythmogenic cardiomyopathy (n=1). Implantable cardioverter-defibrillator and heart failure medical therapy was evaluated. A novel homozygous desmoplakin (DSP) mutation (p.Ala2110Pro) was identified in a 23-year-old man presenting with early-onset biventricular arrhythmogenic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: